1Y Target$24.65Near-term target
5Y Target$36.73Compound horizon
10Y Target$95.57Long-dated conviction
FCF-$76mTTM · 12/25FFCF is negative (-$76m) — cash-burning phase; acceptable only for pre-profit spec names · TTM computed from 4 most-recent quarters (TTM · 12/25).
Rev+8.3%TTM YoYBRevenue +8.3% — at or above S&P median · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.12totalA-D/E 0.12 — conservative leverage, strong balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S3.1xBP/S 3.1x — in line with software/tech peers
PEG—proxy—PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $2.1b. 9% off the 52-week high of $20.06.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Free cash flow is negative (-$76m) — capital raises or debt issuance likely required; dilution / leverage risk. Currently unprofitable (margin -25.7%) — path to GAAP profitability is the core thesis risk. ROE -39% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $24.65 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $36.73 — requires the platform / technology to reach commercial scale. 10 yr $95.57 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.